FI115054B - Menetelmä terapeuttisesti käyttökelpoisten oksetanonien valmistamiseksi - Google Patents
Menetelmä terapeuttisesti käyttökelpoisten oksetanonien valmistamiseksi Download PDFInfo
- Publication number
- FI115054B FI115054B FI910925A FI910925A FI115054B FI 115054 B FI115054 B FI 115054B FI 910925 A FI910925 A FI 910925A FI 910925 A FI910925 A FI 910925A FI 115054 B FI115054 B FI 115054B
- Authority
- FI
- Finland
- Prior art keywords
- methyl
- oxo
- oxetanyl
- group
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
- C07D305/12—Beta-lactones
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epoxy Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polyesters Or Polycarbonates (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH60490 | 1990-02-26 | ||
CH60490 | 1990-02-26 | ||
CH400590 | 1990-12-17 | ||
CH400590 | 1990-12-17 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI910925A0 FI910925A0 (fi) | 1991-02-26 |
FI910925A FI910925A (fi) | 1991-08-27 |
FI115054B true FI115054B (fi) | 2005-02-28 |
Family
ID=25685091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI910925A FI115054B (fi) | 1990-02-26 | 1991-02-26 | Menetelmä terapeuttisesti käyttökelpoisten oksetanonien valmistamiseksi |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0444482B1 (da) |
JP (1) | JP2753403B2 (da) |
KR (1) | KR0183036B1 (da) |
AT (1) | ATE133167T1 (da) |
AU (1) | AU645291B2 (da) |
CA (1) | CA2035967C (da) |
DE (1) | DE59107262D1 (da) |
DK (1) | DK0444482T3 (da) |
ES (1) | ES2082869T3 (da) |
FI (1) | FI115054B (da) |
GR (1) | GR3019618T3 (da) |
HU (1) | HU218272B (da) |
IE (1) | IE72196B1 (da) |
IL (1) | IL97148A (da) |
MC (1) | MC2226A1 (da) |
NO (1) | NO177055C (da) |
NZ (1) | NZ237170A (da) |
PT (1) | PT96887B (da) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2035972C (en) * | 1990-02-23 | 2006-07-11 | Martin Karpf | Process for the preparation of oxetanones |
CA2098167C (en) * | 1992-06-24 | 2006-12-19 | Dorothea Isler | Foodstuffs and feedstuffs containing a lipase inhibitor |
NL1004559C2 (nl) * | 1996-11-18 | 1998-05-19 | Unilife | Boter. |
US6348492B1 (en) * | 1999-10-29 | 2002-02-19 | 2Pro Chemical | Oxetanone derivatives |
US6342519B2 (en) * | 1999-10-29 | 2002-01-29 | 2 Pro Chemical | Oxetanone derivatives |
CA2358921A1 (en) * | 1999-10-29 | 2001-05-10 | John Jason Gentry Mullins | Oxetanone derivatives |
DE102004009076A1 (de) * | 2004-02-23 | 2005-10-27 | Solvay Pharmaceuticals Gmbh | Alkylcarbamat-substituierte β-Lactone, Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
US7074822B2 (en) | 2004-02-23 | 2006-07-11 | Solvay Pharmaceuticals Gmbh | Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing them |
US8258321B2 (en) | 2007-10-31 | 2012-09-04 | Burnham Institute For Medical Research | Beta-lactone compounds |
SG11202000239XA (en) * | 2017-07-12 | 2020-02-27 | Mayo Found Medical Education & Res | Compounds for the reducing lipotoxic damage |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS608117B2 (ja) * | 1977-02-08 | 1985-02-28 | 財団法人微生物化学研究会 | 新生理活性物質エステラスチンおよびその製造法 |
GB2023604B (en) * | 1978-05-25 | 1982-07-28 | Microbial Chem Res Found | Physiologically active derivatives of esterastin and production thereof |
JPH0669130B2 (ja) * | 1984-08-09 | 1994-08-31 | 三菱電機株式会社 | 遅延線 |
-
1991
- 1991-02-05 IL IL9714891A patent/IL97148A/en active IP Right Grant
- 1991-02-07 CA CA002035967A patent/CA2035967C/en not_active Expired - Fee Related
- 1991-02-15 DE DE59107262T patent/DE59107262D1/de not_active Expired - Fee Related
- 1991-02-15 EP EP91102151A patent/EP0444482B1/de not_active Expired - Lifetime
- 1991-02-15 ES ES91102151T patent/ES2082869T3/es not_active Expired - Lifetime
- 1991-02-15 AT AT91102151T patent/ATE133167T1/de not_active IP Right Cessation
- 1991-02-15 DK DK91102151.7T patent/DK0444482T3/da not_active Application Discontinuation
- 1991-02-20 NZ NZ237170A patent/NZ237170A/en unknown
- 1991-02-20 AU AU71228/91A patent/AU645291B2/en not_active Ceased
- 1991-02-20 HU HU61/91A patent/HU218272B/hu not_active IP Right Cessation
- 1991-02-21 MC MC912172A patent/MC2226A1/xx unknown
- 1991-02-22 JP JP3131730A patent/JP2753403B2/ja not_active Expired - Fee Related
- 1991-02-25 IE IE63191A patent/IE72196B1/en not_active IP Right Cessation
- 1991-02-25 NO NO910729A patent/NO177055C/no unknown
- 1991-02-26 PT PT96887A patent/PT96887B/pt not_active IP Right Cessation
- 1991-02-26 KR KR1019910003075A patent/KR0183036B1/ko not_active IP Right Cessation
- 1991-02-26 FI FI910925A patent/FI115054B/fi not_active IP Right Cessation
-
1996
- 1996-04-09 GR GR960401013T patent/GR3019618T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPH0770099A (ja) | 1995-03-14 |
EP0444482B1 (de) | 1996-01-17 |
NO910729D0 (no) | 1991-02-25 |
PT96887B (pt) | 1998-09-30 |
FI910925A (fi) | 1991-08-27 |
ES2082869T3 (es) | 1996-04-01 |
EP0444482A3 (en) | 1991-12-04 |
HUT56557A (en) | 1991-09-30 |
AU7122891A (en) | 1991-08-29 |
IL97148A (en) | 1996-11-14 |
IL97148A0 (en) | 1992-05-25 |
GR3019618T3 (en) | 1996-07-31 |
EP0444482A2 (de) | 1991-09-04 |
NO177055C (no) | 1995-07-12 |
KR0183036B1 (ko) | 1999-05-01 |
CA2035967C (en) | 2001-10-16 |
MC2226A1 (fr) | 1993-02-02 |
CA2035967A1 (en) | 1991-08-27 |
NO177055B (no) | 1995-04-03 |
DK0444482T3 (da) | 1996-05-06 |
FI910925A0 (fi) | 1991-02-26 |
KR910021391A (ko) | 1991-12-20 |
DE59107262D1 (de) | 1996-02-29 |
JP2753403B2 (ja) | 1998-05-20 |
NZ237170A (en) | 1993-12-23 |
PT96887A (pt) | 1991-10-31 |
IE910631A1 (en) | 1991-08-28 |
ATE133167T1 (de) | 1996-02-15 |
NO910729L (no) | 1991-08-27 |
AU645291B2 (en) | 1994-01-13 |
IE72196B1 (en) | 1997-03-26 |
HU218272B (en) | 2000-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5466708A (en) | Oxetanones | |
JP3569550B2 (ja) | 縮合二環式環含有化合物およびその製造法 | |
RU2135515C1 (ru) | Карбаматы и карбамиды, индуцирующие производство цитокинов | |
DE69309047T2 (de) | Hydroxamsäure enthaltende collagenase-inhibitoren und cytokinaktivitätsinhibitoren | |
FI115054B (fi) | Menetelmä terapeuttisesti käyttökelpoisten oksetanonien valmistamiseksi | |
HUT74511A (en) | Metalloproteinase inhibitors, pharmaceutical compns. contg. them and process to prepare the said compds. | |
DE2925945C2 (da) | ||
AU3895900A (en) | Novel compounds and compositions as protease inhibitors | |
CA1101846A (en) | Derivatives of 4-hydroxy-phenylglycine | |
US5109000A (en) | Thiol carboxylic acid derivatives and their use as collagenase inhibitor | |
WO2007144169A2 (en) | Entacapone-derivatives | |
WO2002060880A1 (fr) | Derives d'acyclonucleosides pyrimidiniques, leur procede de preparation et leur utilisation | |
JPH06104649B2 (ja) | アミノ酸誘導体抗痙攣剤 | |
HUT57705A (en) | Process for producing acat-inhibitors | |
FR2500832A1 (fr) | Composes de derives de bis (carboxamide) et composition pharmaceutique comprenant ces composes | |
US6110933A (en) | Amino acid derivatives and their use as phospholipase A2 inhibitor | |
EP0520427B1 (en) | Cyclopropenone derivatives | |
CZ281839B6 (cs) | Derivát aminokyseliny, způsob jeho přípravy a farmaceutický prostředek, který ho obsahuje | |
US7777071B2 (en) | Production of carnitine conjugate intermediates | |
JP3361836B2 (ja) | アミノ酸誘導体 | |
EP0925786A1 (en) | Remedies for ischemic diseases | |
CA2049390A1 (en) | Novel peptide derivatives and their pharmaceutical use | |
JPH0788334B2 (ja) | N−メチルフエニルセリン誘導体 | |
KR20010020452A (ko) | 금속 단백질 분해효소 억제제 | |
JPH09249628A (ja) | フェノール誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Ref document number: 115054 Country of ref document: FI |
|
MA | Patent expired |